Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 269

1.

Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.

Sierra F, Forero JD, Rey M, Botero ML, Cárdenas A.

Aliment Pharmacol Ther. 2013 Jun;37(12):1165-71. doi: 10.1111/apt.12329. Epub 2013 May 8.

2.

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

Lee JM, Breslin NP, Hyde DK, Buckley MJ, O'Morain CA.

Aliment Pharmacol Ther. 1999 Apr;13(4):489-96.

3.

Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.

Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.

Clin Ther. 2008 Mar;30(3):528-34. doi: 10.1016/j.clinthera.2008.03.009.

PMID:
18405790
4.

Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.

Ellenrieder V, Boeck W, Richter C, Marre R, Adler G, Glasbrenner B.

Scand J Gastroenterol. 1999 Aug;34(8):750-6.

PMID:
10499474
5.
6.

What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.

Onal IK, Gokcan H, Benzer E, Bilir G, Oztas E.

Clin Res Hepatol Gastroenterol. 2013 Dec;37(6):642-6. doi: 10.1016/j.clinre.2013.05.005. Epub 2013 Jun 21.

PMID:
23796974
7.

Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.

Pilotto A, Franceschi M, Leandro G, Bozzola L, Fortunato A, Rassu M, Meli S, Soffiati G, Scagnelli M, Di Mario F, Valerio G.

J Gastroenterol Hepatol. 1999 May;14(5):468-75.

PMID:
10355512
8.

Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.

Louw JA, Van Rensburg CJ, Moola S, Kotze D, Marks IN.

Aliment Pharmacol Ther. 1998 Sep;12(9):881-5.

9.

Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.

Gisbert JP, Perez-Aisa A, Rodrigo L, Molina-Infante J, Modolell I, Bermejo F, Castro-Fernández M, Antón R, Sacristán B, Cosme A, Barrio J, Harb Y, Gonzalez-Barcenas M, Fernandez-Bermejo M, Algaba A, Marín AC, McNicholl AG; H. pylori Study Group of the Spanish Gastroenterology Association.

Dig Dis Sci. 2014 Feb;59(2):383-9. doi: 10.1007/s10620-013-2900-x. Epub 2013 Oct 15.

PMID:
24126798
10.

Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.

Murakami K, Okimoto T, Kodama M, Sato R, Watanabe K, Fujioka T.

J Clin Gastroenterol. 2008 Feb;42(2):139-42. doi: 10.1097/MCG.0b013e31802cbc1a.

PMID:
18209581
11.

Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.

Köksal AS, Parlak E, Filik L, Yolcu OF, Odemiş B, Ulker A, Saşmaz N, Ozden A, Sahin B.

J Gastroenterol Hepatol. 2005 Apr;20(4):637-42.

PMID:
15836716
12.

Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.

Nista EC, Candelli M, Zocco MA, Cremonini F, Ojetti V, Finizio R, Spada C, Cammarota G, Gasbarrini G, Gasbarrini A.

Am J Gastroenterol. 2006 Sep;101(9):1985-90.

PMID:
16968503
13.

Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens.

Liu MK, Wu IC, Lu CY, Kuo CH, Yu FJ, Liu CJ, Hsu PI, Hsu WH, Su YC, Chen A, Wu DC, Kuo FC, Chen JJ.

Kaohsiung J Med Sci. 2013 Jul;29(7):379-84. doi: 10.1016/j.kjms.2012.11.006. Epub 2013 Jan 12.

14.

Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.

Stack WA, Knifton A, Thirlwell D, Cockayne A, Jenkins D, Hawkey CJ, Atherton JC.

Am J Gastroenterol. 1998 Oct;93(10):1909-13.

PMID:
9772054
15.

Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.

Georgopoulos SD, Xirouchakis E, Martinez-Gonzalez B, Sgouras DN, Spiliadi C, Mentis AF, Laoudi F.

Helicobacter. 2013 Dec;18(6):459-67. doi: 10.1111/hel.12062. Epub 2013 May 29.

PMID:
23714140
16.
17.

Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases.

Gomollón F, Ducóns JA, Ferrero M, García Cabezudo J, Guirao R, Simón MA, Montoro M.

Helicobacter. 1999 Dec;4(4):222-5.

PMID:
10597390
18.

CagA status and Helicobacter pylori eradication among dyspeptic patients.

Magalhães AF, Carvalhaes A, Natan-Eisig J, Paraíso-Ferraz JG, Trevisan M, Zaterkaad S.

Gastroenterol Hepatol. 2005 Oct;28(8):441-4.

PMID:
16185577
19.

Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.

Grimley CE, Penny A, O'sullivan M, Shebani M, Lismore JR, Cross R, Illing RC, Loft DE, Nwokolo CU.

Aliment Pharmacol Ther. 1999 Jul;13(7):869-73.

20.

[Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].

Kayser S, Flury R, Zbinden R, Fried M, Wirth HP.

Schweiz Med Wochenschr. 1997 Apr 26;127(17):722-7. German.

PMID:
9221483

Supplemental Content

Support Center